Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shigeto Negi is active.

Publication


Featured researches published by Shigeto Negi.


Tetrahedron | 2001

Large scale synthesis of N-benzyl-4-formylpiperidine through partial reduction of esters using aluminum hydride reagents modified with pyrrolidine

Taichi Abe; Toyokazu Haga; Shigeto Negi; Yukio Morita; Keizou Takayanagi; Kimio Hamamura

Abstract The modification of sodium bis(2-methoxyethoxy)aluminum hydride (SMEAH) with pyrrolidine provided a highly selective reducing agent to transform N -benzyl-4-ethoxycarbonylpiperidine into N -benzyl-4-formylpiperidine 1 under mild conditions. However, this simple modification led to a significant amount of N -benzyl-4-(pyrrolidin-1-ylmethyl)piperidine 4 due to overreduction of an intermediate. Our extensive research revealed that an alkaline base such as potassium tert -butoxide could suppress the formation of the by-product to give the desired aldehyde, enabling us to establish a viable synthetic process for a key intermediate of donepezil hydrochloride. The potential applications of this reagent are also described.


Synthetic Communications | 1980

Oxidation of 4-Oxo-4H-1-Benzopyran-3-Carboxaldehydes with N-Bromosuccinimide

Yoshimasa Machida; Seiichiro Nomoto; Shigeto Negi; Hironori Ikuta; Isao Saito

Abstract 4-Oxo-4-H-1-benzopyran-3-carboxylic acids and their derivatives (esters and amides), 2, are known to possess interesting pharmacological activities.1 As part of our synthetic studies of biologically active compounds, we needed to prepare a variety of 2 (carboxylic acids, esters, amides, etc.). An elegant method for the preparation of 4-oxo-4H-1-benzopyran-3-carboxaldehydes, 1, was reported independently by Nohara et al. 2 and Harnish.3 However, despite a rather extensive effort by Nohara et al., the oxidation of 1 to 2 (Y=OH) has not been realized in good yield; thus the yields by Jones oxidation, the best reported method, ranged only from 9.5 to 39%.4


Synthetic Communications | 1997

Practical Oxirane Ring Opening with In Situ Prepared LiCN; Synthesis of (2S,3R)-3-(2,4-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)-1-butanenitrile

Akihiko Tsuruoka; Shigeto Negi; Manabu Yanagisawa; Kazumasa Nara

Abstract Trisubstituted oxirane 1 was regiospecifically opened with LiCN in situ prepared from acetone cyanohydrin and LiH to provide the corresponding β-hydroxy nitrile 2 in satisfactory yield, enabling us to manufacture a key intermediate for a new antifungal agent on a multi-kg scale. Some applications of this method to the ring opening of other oxiranes and nucleophilic substitution are also described.


Journal of Labelled Compounds and Radiopharmaceuticals | 1996

Synthesis of a radiolabelled new oral cephalosporin, E1101

Shigeto Negi; Yuki Komatsu; Akihiko Tsuruoka; Yuji Uemura

The new broad-spectrum oral antibacterial agent E1101, has been labelled in the C-2 position of the aminothiazole ring using [ 14 C]thiourea. The cephalosporin analog was synthesized in 5 steps and is suitable for metabolism and disposition studies.


Archive | 2000

Fused imidazole compounds and remedies for diabetes mellitus

Hiroshi Akamatsu; Osamu Asano; Toyokazu Haga; Hitoshi Harada; Kenji Hayashi; Tatsuo Horizoe; Takashi Inoue; Tsutomu Kawata; Seiichi Kobayashi; Hiroe Minami; Manabu Murakami; Junsaku Nagaoka; Toshihiko Naito; Shigeto Negi; Kaya Ohashi; Naoki Ozeki; Toshikazu Shimizu; Naoyuki Shimomura; Isao Tanaka; Nobuhisa Watanabe; Nobuyuki Yasuda; Seiji Yoshikawa


Synthesis | 1996

SYNTHESIS OF (2R)-1-(4-CHLORO-2-PYRIDYL)-2-(2-PYRIDYL)ETHYLAMINE : A SELECTIVE OXIME REDUCTION AND CRYSTALLIZATION-INDUCED ASYMMETRIC TRANSFORMATION

Shigeto Negi; Masayuki Matsukura; Masanori Mizuno; Kazutoshi Miyake; Norio Minami


Archive | 1990

3-propenylcephem derivative

Takashi Kamiya; Toshihiko Naito; Shigeto Negi; Yuuki Komatu; Yasunobu Kai; Takaharu Nakamura; Isao Sugiyama; Yoshimasa Machida; Seiichiro Nomoto; Kyosuke Kitoh; Kanemasa Katsu; Hiroshi Yamauchi


Archive | 1989

Process for the preparation of cephem derivatives and intermediates therefor

Takashi Kamiya; Toshihiko Naito; Yuuki Komatu; Yasunobu Kai; Takaharu Nakamura; Manabu Sasho; Shigeto Negi; Isao Sugiyama; Kanemasa Katsu; Hiroshi Yamauchi


Archive | 2000

Condensed imidazole compounds and a therapeutic agent for diabetes mellitus

Osamu Asano; Hitoshi Harada; Seiji Yoshikawa; Nobuhisa Watanabe; Takashi Inoue; Tatsuo Horizoe; Nobuyuki Yasuda; Kaya Ohashi; Hiroe Minami; Junsaku Nagaoka; Manabu Murakami; Seiichi Kobayashi; Isao Tanaka; Tsutomu Kawata; Naoyuki Shimomura; Hiroshi Akamatsu; Naoki Ozeki; Toshikazu Shimizu; Kenji Hayashi; Toyokazu Haga; Shigeto Negi; Toshihiko Naito


Archive | 1987

3-propenylcephem derivative, preparation thereof, chemical intermediates therein, pharmaceutical composition and use

Takashi Kamiya; Toshihiko Naito; Shigeto Negi; Yuuki Komatu; Yasunobu Kai; Takaharu Nakamura; Isao Sugiyama; Yoshimasa Machida; Seiichiro Nomoto; Kyosuke Kitoh; Kanemasa Katsu; Hiroshi Yamauchi

Researchain Logo
Decentralizing Knowledge